TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T04643 XX ID T04643 XX DT 27.07.2001 (created); dkl. DT 15.11.2007 (updated); bch. CO Copyright (C), QIAGEN. XX FA c-Ski XX SY SKI; SKV; v-ski sarcoma viral oncogene homolog (avian). XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G006726 SKI; HGNC: SKI. XX SZ 728 AA; 80.0 kDa (cDNA) (calc.). XX SQ MEAAAGGRGCFQPHPGLQKTLEQFHLSSMSSLGGPAAFSARWAQEAYKKESAKEAGAAAV SQ PAPVPAATEPPPVLHLPAIQPPPPVLPGPFFMPSDRSTERCETVLEGETISCFVVGGEKR SQ LCLPQILNSVLRDFSLQQINAVCDELHIYCSRCTADQLEILKVMGILPFSAPSCGLITKT SQ DAERLCNALLYGGAYPPPCKKELAASLALGLELSERSVRVYHECFGKCKGLLVPELYSSP SQ SAACIQCLDCRLMYPPHKFVVHSHKALENRTCHWGFDSANWRAYILLSQDYTGKEEQARL SQ GRCLDDVKEKFDYGNKYKRRVPRVSSEPPASIRPKTDDTSSQSPAPSEKDKPSSWLRTLA SQ GSSNKSLGCVHPRQRLSAFRPWSPAVSASEKELSPHLPALIRDSFYSYKSFETAVAPNVA SQ LAPPAQQKVVSSPPCAAAVSRAPEPLATCTQPRKRKLTVDTPGAPETLAPVAAPEEDKDS SQ EAEVEVESREEFTSSLSSLSSPSFTSSSSAKDLGSPGARALPSAVPDAAAPADAPSGLEA SQ ELEHLRQALEGGLDTKEAKEKFLHEVVKMRVKQEEKLSAALQAKRSLHQELEFLRVAKKE SQ KLREATEAKRNLRKEIERLRAENEKKMKEANESRLRLKRELEQARQARVCDKGCEAGRLR SQ AKYSAQIEDLQVKLQHAEADREQLRADLLREREAREHLEKVVKELQEQLWPRARPEAAGS SQ EGAAELEP XX SC translated from EMBL #X15218 XX FT 1 309 Smad interaction domain [1]. FT 80 192 PF02437; SKI/SNO/DAC family. FT 197 261 interaction domain with Gli3 [3]. FT 246 715 PF00478; IMP dehydrogenase / GMP reductase domain. FT 338 490 interaction domain with Smad-2/Smad-3 [1]. XX FF interacts with Smad-2/Smad-3 in a TGF-beta dependent manner and Smad-4 is also incorporated in this complex [1]; FF is has two distinct Smad interaction domains [1]; FF represses transactivation by TGF-beta [1]; FF it is incorporated in the DNA binding complex of Smads [1]; FF it competes with p300 in binding to Smad-3 [1]; FF it recruits HDAC to Smads [1]; FF it inhibits Smad-associated HAT activity [1]; XX IN T14622 sin3a; human, Homo sapiens. IN T10378 Smad3; human, Homo sapiens. IN T13998 Smad4; Mammalia. XX DR TRANSPATH: MO000028476. DR EMBL: X15218; DR UniProtKB: P12755; XX RN [1]; RE0016412. RX PUBMED: 10575014. RA Akiyoshi S., Inoue H., Hanai J., Kusanagi K., Nemoto N., Miyazono K., Kawabata M. RT c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. RL J. Biol. Chem. 274:35269-35277 (1999). RN [2]; RE0047884. RX PUBMED: 14525983. RA Wu K., Yang Y., Wang C., Davoli M. A., D'Amico M., Li A., Cveklova K., Kozmik Z., Lisanti M. P., Russell R. G., Cvekl A., Pestell R. G. RT DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. RL J. Biol. Chem. 278:51673-51684 (2003). RN [3]; RE0025535. RX PUBMED: 8706131. RA Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J. W., Elledge S. J. RT SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. RL Cell 86:263-74 (1996). XX //